Helpful resources to learn more about DecisionDx-SCC
Hear from experts and learn more about improving risk assessment in DecisionDx-SCC patients.
Individualized risk information: An introduction to DecisionDx-SCC
Tumor biology matters
DecisionDx-SCC is a genomic test that looks at the tumor biology of squamous cell carcinoma (SCC) of the skin to better understand the risk of cancer spreading to other parts of body
Expert opinions on the treatment and
management of squamous cell carcinoma.
From Diagnosis to Determination: Don's Skin Cancer Journey of Hope, Clarity and a Plan
Meet Don, a skin cancer survivor who turned fear into power with the help of a strong medical team and the DecisionDx-SCC test. From a surprise diagnosis to the emotional relief of being cancer-free, Don shares how knowing his risk gave him the confidence to move forward with clarity, peace of mind.
Explore on-demand webinars
AHNS DecisionDx–SCC Webinar: Identifying the Risk of Metastasis in cSCC and cSCC-HN Patients
Jason Newman, MD, FACS, Professor of Otorhinolaryngology – Head and Neck Surgery, University of Pennsylvania
CME/CE: N/A
Maui Derm DecisionDx-SCC Product Theater: Identifying the Risk of Metastasis in cSCC Patients with One or More Risk Factors.
Faculty: Brent Moody, MD, FACP, FAAD, Fellow, American College of Mohs Surgery
CME/CE: N/A
Enhanced Metastatic Risk Assessment in Cutaneous Squamous Cell Carcinoma with the 40-Gene Expression Profile Test: An Interview with the Lead Author of DecisionDx-SCC’s Validation Study
Sherrif F. Ibrahim, MD, PhD, Assistant Professor, Department of Dermatology, University of Rochester Medical Center
CME/CE: N/A
The DecisionDx-SCC test is a game changer”
Phil Andrews, NP/PA
